Ingram’s: A Genetic Condition

Kansas City research hospitals and clinics are exploring building blocks of life in broad-based effort to improve outcomes and extend lives.

Ingram's talked to Dr. Marc Roth and Blake Buzard with Saint Luke's Hospital Center for Precision Oncology about the rapid pace of advances in precision medicine.

“If you look at just 2024, with the new oncology drug approvals by the FDA, about half of them were for targeted therapies and precision therapeutics. That number grows each year,” said Dr. Roth. “It’s not just the drug development, but also the ways we identify who will benefit from these drugs. With sequencing platforms or testing on patients with advanced cancer, as those become more sensitive and are better able to detect specific molecular aberrations, locations and numbers of genes they detect, we’re able to find more patients with these targetable aberrations and find new ones.”

Read the full Ingram’s article: A Genetic Condition.

Related Content

Nov. 29, 2024

Health News You Can Use: Prostate and Testicular Cancer
Dr. Ryan Miller, urologist at Advanced Urologic Associates at Saint Luke’s East Hospital, joins us in raising awareness and providing educational opportunities for men’s health issues.
Nov. 26, 2024

FOX4: Saint Luke's Patient Living with Rare Cancer Starts Foundation to Help Others
More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.
Oct. 28, 2024

KSHB: Saint Luke's Doctor Starts Cancer Nonprofit in Ghana
Dr. Appiah spoke with KSHB about her passion for giving back to her home country and raising awareness for all types of cancer, with it all starting with breast cancer awareness.